Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN INTL

5.020
+0.0400.80%
Volume:7.38M
Turnover:37.09M
Market Cap:40.99B
PE:-8.59
High:5.090
Open:5.000
Low:4.980
Close:4.980
Loading ...

MEET48「WEB3.0 Annual Global Idol Popularity Final Vote」 Breaking News: As of the latest update, a total of 16.92 million IDOL tokens have been used in the vote, accounting for 0.35% of the total supply.

Blockbeats
·
01 Jul

Shanghai Henlius Biotech Inc. Enters Licensing Partnership with FBD Biologics Limited for HCB101

Reuters
·
30 Jun

Fosun International Down 1%, Unit Henlius Biotech Up 5%, as Board Approves Incentive Plans

MT Newswires Live
·
30 Jun

Shanghai Fosun Pharmaceutical Conducts Buyback of 532,800 Shares at Average Price 25.07

Reuters
·
30 Jun

Fosun International Grants Share Options, Share Awards

MT Newswires Live
·
30 Jun

Shanghai Fosun Pharmaceutical Reports Disposal of Common Shares in Nature's Sunshine Products Inc

Reuters
·
28 Jun

Fosun International Limited Announces New Compensation Plan with Options and Share Awards for Directors and Employees

Reuters
·
27 Jun

Shanghai Henlius Biotech Inc. Announces New Appointments to Nomination Committee and Proposed Amendments to Governance Measures

Reuters
·
27 Jun

Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake

Dow Jones
·
26 Jun

Shanghai Fosun Pharmaceutical Completes Buyback of 810,300 Shares at RMB 24.63

Reuters
·
26 Jun

Fosun International's Serplulimab Gains Regulatory Approval in the UK and India for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer

Reuters
·
25 Jun

Shanghai Fosun Pharma's Board Elects Chairman

Reuters
·
24 Jun

Fosun Pharma Announces New Leadership Team, Appoints Chen Yuqing as Chairman and Liu Yi as CEO

Reuters
·
24 Jun

Sisram Medical Ltd. Conducted Annual General Meeting

Reuters
·
24 Jun

Shanghai Henlius Biotech Announces First Patient Dosed in Japanese Bridging Study of Serplulimab for Extensive-Stage Small Cell Lung Cancer

Reuters
·
24 Jun

Gland Pharma Gets EIR From U.S. FDA For Company’S JNPC Facility, Visakhapatnam

Reuters
·
24 Jun

Shanghai Fosun Pharmaceutical Conducts Share Buyback of 1,300,000 Units at RMB 24.77

Reuters
·
19 Jun

Shanghai Fosun Pharmaceutical Conducts Buyback of 1,245,300 Shares for RMB 30.99 Million

Reuters
·
18 Jun

Fosun International Sees Improving Liquidity, Fitch Says

MT Newswires Live
·
18 Jun

Teva Pharmaceuticals Partners with Fosun Pharma to Develop Innovative Cancer Therapy

Reuters
·
16 Jun